1. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. (August 2020) Authors: Wong, Grace Lai-Hung; Wong, Vincent Wai-Sun; Thompson, Alex; Jia, Jidong; Hou, Jinlin; Lesmana, Cosmas Rinaldi Adithya; Susilo, Adityo; Tanaka, Yasuhito; Chan, Wah-Kheong; Gane, Ed; Ong-Go, Arlinking K; Lim, Seng-Gee; Ahn, Sang Hoon; Yu, Ming-Lung; Piratvisuth, Teerha; Chan, Henry Lik-Yuen Journal: Lancet gastroenterology and hepatology Issue: Volume 5:Number 8(2020) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Issue 10324 (5th February 2022) Authors: Polizzotto, Mark N.; Nordwall, Jacqueline; Babiker, Abdel G.; Phillips, Andrew; Vock, David M.; Eriobu, Nnakelu; Kwaghe, Vivian; Paredes, Roger; Mateu, Lourdes; Ramachandruni, Srikanth; Narang, Rajeev; Jain, Mamta K.; Lazarte, Susana M.; Baker, Jason V.; Frosch, Anne E.P.; Poulakou, Garyfallia; S... Journal: Lancet Issue: Volume 399:Issue 10324(2022) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗